Telesis Bio Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2020 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Telesis Bio Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2020 to Q3 2024.
  • Telesis Bio Inc. Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2024 was $7.9M, a 71.5% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $7.9M -$19.8M -71.5% Sep 30, 2024 10-Q 2024-11-07
Q2 2024 $26.6M -$1.36M -4.86% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $28.3M +$6.94M +32.5% Mar 31, 2024 10-Q 2024-05-10
Q4 2023 $25.9M +$24.2M +1460% Dec 31, 2023 10-Q 2024-11-07
Q3 2023 $27.7M +$25.9M +1395% Sep 30, 2023 10-Q 2023-11-13
Q2 2023 $27.9M +$26.2M +1499% Jun 30, 2023 10-Q 2023-08-11
Q1 2023 $21.3M +$19.3M +958% Mar 31, 2023 10-Q 2023-05-12
Q4 2022 $1.66M -$621K -27.2% Dec 31, 2022 10-K 2024-03-29
Q3 2022 $1.85M +$1.29M +229% Sep 30, 2022 10-Q 2022-11-09
Q2 2022 $1.75M -$1.03M -37% Jun 30, 2022 10-Q 2022-08-10
Q1 2022 $2.02M Mar 31, 2022 10-Q 2022-05-11
Q4 2021 $2.28M -$809K -26.2% Dec 31, 2021 10-K 2023-03-22
Q3 2021 $564K Sep 30, 2021 10-Q 2021-11-10
Q2 2021 $2.78M Jun 30, 2021 10-Q 2021-08-11
Q4 2020 $3.09M Dec 31, 2020 10-K 2022-03-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.